PCA
MDCO

Private Capital Advisors’s Medicines Co MDCO Stock Holding History

Private Capital Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-51,621
Closed -$1.59M – 117
2013
Q2 		$1.59M Buy
+51,621
New +$1.73M 0.59% 62

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Private Capital Advisors's MDCO Position: Q3 2013 in Review

Private Capital Advisors sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 51,621 shares — an estimated $1.59M sold.

Private Capital Advisors first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $1.59M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Private Capital Advisors reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
  • Private Capital Advisors sold 51,621 Medicines Co shares in Q3 2013, an estimated $1.59M.
  • Private Capital Advisors first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
  • Private Capital Advisors's Medicines Co position peaked at $1.59M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Private Capital Advisors's 13F filing for Q3 2013, filed 18 Oct 2013.